| P50 | author | Hyun Jae Kang | Q90897576 |
| | Byung-Hee Oh | Q41652919 |
| P2093 | author name string | Han-Mo Yang | |
| | Hyo-Soo Kim | |
| | Hyun-Ju Cho | |
| | Wonjae Lee | |
| | Jung-Won Suh | |
| | Dong-A Kwon | |
| P2860 | cites work | Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis | Q74206339 |
| | The adenoma prevention with celecoxib and prevention of colorectal sporadic adenomatous polyps trials: stepping stones to progress | Q79776008 |
| | Altered kidney graft high-energy phosphate metabolism in kidney-transplanted end-stage renal disease type 1 diabetic patients: a cross-sectional analysis of the effect of kidney alone and kidney-pancreas transplantation | Q79842913 |
| | In vitro effects of clopidogrel on the platelet-subendothelium interaction, platelet thromboxane and endothelial prostacyclin production, and nitric oxide synthesis | Q28166439 |
| | Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers | Q28168971 |
| | Platelet-collagen interaction: is GPVI the central receptor? | Q28185377 |
| | Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers | Q28193687 |
| | Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling | Q28198809 |
| | Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease | Q28200423 |
| | Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT) | Q28210559 |
| | Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials | Q28213612 |
| | Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial | Q28217835 |
| | Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study | Q28219713 |
| | The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis | Q29616121 |
| | Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention | Q29620087 |
| | Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study | Q29620671 |
| | The coxibs, selective inhibitors of cyclooxygenase-2. | Q34086325 |
| | Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis | Q34247727 |
| | Coxibs and cardiovascular disease | Q34356732 |
| | Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2 | Q34803113 |
| | Cyclooxygenase inhibition and cardiovascular risk | Q36215336 |
| | Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. | Q36591918 |
| | Very late thrombosis of a drug-eluting stent after discontinuation of dual antiplatelet therapy in a patient treated with both drug-eluting and bare-metal stents | Q37408671 |
| | Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice | Q37511097 |
| | Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model | Q45197823 |
| | Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation | Q46408232 |
| | Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study | Q46481473 |
| | Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial | Q73423989 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspirin | Q18216 |
| | platelet aggregation inhibitors | Q721432 |
| | clopidogrel | Q410237 |
| P304 | page(s) | 321-327 | |
| P577 | publication date | 2010-07-26 | |
| P1433 | published in | Korean circulation journal | Q26842331 |
| P1476 | title | Celecoxib does not attenuate the antiplatelet effects of aspirin and clopidogrel in healthy volunteers | |
| | Celecoxib Does Not Attenuate the Antiplatelet Effects of Aspirin and Clopidogrel in Healthy Volunteers | |
| P478 | volume | 40 | |